Evidence map›Paper›PMID 23376354›Full record

ReviewPharmacological research2013

Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches.

Biny K Joseph, Keshari M Thakali, Christopher L Moore, Sung W Rhee

Abstract readReview
In one paragraph

Review in Pharmacological research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. CaInflammation and regeneration · 2024
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. BKHypertension research : official journal of the Japanese Society of Hypertension · 2018
    Article
  9. KMicrocirculation (New York, N.Y. : 1994) · 2018
    Review
  10. Review
  11. Article
  12. Shaker-related voltage-gated KMicrocirculation (New York, N.Y. : 1994) · 2018
    Article
  13. Article
  14. Review
  15. Contribution of KCirculation research · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Biny K JosephVenenum Biodesign, 8 Black Forest Road, Hamilton, NJ 08691, USA.
Keshari M Thakali
Christopher L Moore
Sung W Rhee

Funding

PSD95 scaffolding of vascular K+ channels in hypertensionR01HL097107 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI RHEE, SUNG W · 2010 to 2014
$1.8M
L-type calcium channels are silent during depolarization of venous smooth muscleF32HL095284 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI THAKALI, KESHARI · 2009 to 2011
$146k
NHLBI NIH HHS F32 HL095284NHLBI NIH HHS F32 HL095284-03NHLBI NIH HHS R01 HL097107
6 · The paper itself

Abstract

Ion channels are multimeric, transmembrane proteins that selectively mediate ion flux across the plasma membrane in a variety of cells including vascular smooth muscle cells (VSMCs). The dynamic interplay of Ca(2+) and K(+) channels on the plasma membrane of VSMCs plays a pivotal role in modulating the vascular tone of small arteries and arterioles. The abnormally-elevated arterial tone observed in hypertension thus points to an aberrant expression and function of Ca(2+) and K(+) channels in the VSMCs. In this short review, we focus on the three well-studied ion channels in VSMCs, namely the L-type Ca(2+) (CaV1.2) channels, the voltage-gated K(+) (KV) channels, and the large-conductance Ca(2+)-activated K(+) (BK) channels. First, we provide a brief overview on the physiological role of vascular CaV1.2, KV and BK channels in regulating arterial tone. Second, we discuss the current understanding of the expression changes and regulation of CaV1.2, KV and BK channels in the vasculature during hypertension. Third, based on available proof-of-concept studies, we describe the potential therapeutic approaches targeting these vascular ion channels in order to restore blood pressure to normotensive levels.

Indexed as

AnimalsAntihypertensive AgentsCalcium ChannelsHumansHypertensionIon Channel GatingMolecular Targeted TherapyMuscle, Smooth, VascularPotassium ChannelsProtein SubunitsAntihypertensive AgentsCalcium ChannelsPotassium ChannelsProtein Subunits

Identifiers

PMID23376354
PMCPMC3607210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.